1. Home
  2. GDHG vs SYBX Comparison

GDHG vs SYBX Comparison

Compare GDHG & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDHG
  • SYBX
  • Stock Information
  • Founded
  • GDHG 2008
  • SYBX N/A
  • Country
  • GDHG China
  • SYBX United States
  • Employees
  • GDHG N/A
  • SYBX N/A
  • Industry
  • GDHG Services-Misc. Amusement & Recreation
  • SYBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GDHG Consumer Discretionary
  • SYBX Health Care
  • Exchange
  • GDHG Nasdaq
  • SYBX Nasdaq
  • Market Cap
  • GDHG 19.4M
  • SYBX 16.4M
  • IPO Year
  • GDHG 2023
  • SYBX N/A
  • Fundamental
  • Price
  • GDHG $7.56
  • SYBX $1.65
  • Analyst Decision
  • GDHG
  • SYBX
  • Analyst Count
  • GDHG 0
  • SYBX 0
  • Target Price
  • GDHG N/A
  • SYBX N/A
  • AVG Volume (30 Days)
  • GDHG 31.3K
  • SYBX 19.5K
  • Earning Date
  • GDHG 07-11-2025
  • SYBX 11-11-2025
  • Dividend Yield
  • GDHG N/A
  • SYBX N/A
  • EPS Growth
  • GDHG N/A
  • SYBX N/A
  • EPS
  • GDHG N/A
  • SYBX N/A
  • Revenue
  • GDHG $16,666,899.00
  • SYBX N/A
  • Revenue This Year
  • GDHG N/A
  • SYBX N/A
  • Revenue Next Year
  • GDHG N/A
  • SYBX N/A
  • P/E Ratio
  • GDHG N/A
  • SYBX N/A
  • Revenue Growth
  • GDHG N/A
  • SYBX N/A
  • 52 Week Low
  • GDHG $2.40
  • SYBX $0.90
  • 52 Week High
  • GDHG $1,968.75
  • SYBX $1.96
  • Technical
  • Relative Strength Index (RSI)
  • GDHG 45.01
  • SYBX 68.68
  • Support Level
  • GDHG $7.44
  • SYBX $1.45
  • Resistance Level
  • GDHG $7.85
  • SYBX $1.54
  • Average True Range (ATR)
  • GDHG 0.86
  • SYBX 0.06
  • MACD
  • GDHG 0.42
  • SYBX 0.02
  • Stochastic Oscillator
  • GDHG 68.65
  • SYBX 98.08

About GDHG Golden Heaven Group Holdings Ltd.

Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

Share on Social Networks: